title: High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe secondary hyperparathyroidism.
authors.forename: Malik
authors.initials: M
authors.lastname: Touam
authors.forename: Victorio
authors.initials: V
authors.lastname: Menoyo
authors.forename: David
authors.initials: D
authors.lastname: Attaf
authors.forename: Henri-Emile
authors.initials: HE
authors.lastname: Thebaud
authors.forename: Tilman B
authors.initials: TB
authors.lastname: Drüeke
mesh_terms: D002118:Calcium / Q000032:analysis; D000069449:Cinacalcet; D015312:Hemodialysis Solutions / Q000737:chemistry*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D009281:Naphthalenes / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D015312:Hemodialysis Solutions; D009281:Naphthalenes; D010281:Parathyroid Hormone; D010710:Phosphates; D014807:Vitamin D; D002118:Calcium; D000069449:Cinacalcet